Search research articles
Contact Us
Filters
Showing results (101-110 of 148) with videos related to
Page
of 15
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 24, 2018
Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS)
Scott R Evans, Dean Follmann, Ying Liu, et al.
The New England Journal of Medicine
|
November 3, 2021
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge
Lindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Plos Pathogens
|
October 3, 2014
Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome
Bruno B Andrade, Amrit Singh, Gopalan Narendran, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 6, 2021
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge
Lindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2022
Anti-PF4 antibodies associated with disease severity in COVID-19
Qingbo Liu, Huiyi Miao, Shuai Li, et al.
Vaccine
|
September 10, 2025
Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial
David J Diemert, Daniel S Graciaa, Bo Zhang, et al.
The New England Journal of Medicine
|
October 12, 2017
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
Stephen B Kennedy, Fatorma Bolay, Mark Kieh, et al.
The Journal of Clinical Investigation
|
August 10, 2023
A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome
David H McDermott, Daniel Velez, Elena Cho, et al.
Science Translational Medicine
|
February 4, 2021
Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis
Yingda L Xie, Veronique R de Jager, Ray Y Chen, et al.
Nature Communications
|
August 29, 2024
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases
Lindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 148) with videos related to
Sort By:
Page
of 15
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 24, 2018
Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS)
Scott R Evans, Dean Follmann, Ying Liu, et al.
The New England Journal of Medicine
|
November 3, 2021
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge
Lindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Plos Pathogens
|
October 3, 2014
Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome
Bruno B Andrade, Amrit Singh, Gopalan Narendran, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 6, 2021
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge
Lindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2022
Anti-PF4 antibodies associated with disease severity in COVID-19
Qingbo Liu, Huiyi Miao, Shuai Li, et al.
Vaccine
|
September 10, 2025
Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial
David J Diemert, Daniel S Graciaa, Bo Zhang, et al.
The New England Journal of Medicine
|
October 12, 2017
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
Stephen B Kennedy, Fatorma Bolay, Mark Kieh, et al.
The Journal of Clinical Investigation
|
August 10, 2023
A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome
David H McDermott, Daniel Velez, Elena Cho, et al.
Science Translational Medicine
|
February 4, 2021
Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis
Yingda L Xie, Veronique R de Jager, Ray Y Chen, et al.
Nature Communications
|
August 29, 2024
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases
Lindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
Page
of 15